BRAINLIFE Brain Tumor Medical Database

Nimustine

Home > Database > Treatment > Nimustine (ACNU)

Contents

Search


Glioblastoma


Aoki T, Takahashi JA, Ueba T, Oya N, Hiraoka M, Matsui K, Fukui T, Nakashima Y, Ishikawa M, Hashimoto N.
Phase II study of nimustine, carboplatin, vincristine, and interferon-beta with radiotherapy for glioblastoma multiforme: experience of the Kyoto Neuro-Oncology Group.
J Neurosurg. 2006 Sep;105(3):385-91.
Abstract


Tomokazu Aoki, Tetsuya Ueba, Jun Takahashi, Natstuo Ooya, Masahiro Hiraoka, Masatsune Ishikwa, and Nobuo Hashimoto
Vincristine, ACNU, Carboplatin and Interferon Beta with Radiation (VAC-FERON-R) for Newly Diagnosed Glioblastoma Multiforme
15th International Conference on Brain Tumor Research and Therapy. Sorrento, Italy. May 24–27, 2003. Abstract No. 3
Neuro-Oncology, Volume 5, CNO 4, October 2003 

In Sil Choi , Se Hoon Lee, Tae-You Kim, Sun Ha Paek, Suzy Kim, Il Han Kim, Dae Seog Heo,Yung-Jue Bang, Dong Gyu Kim, Hee-Won Jung, Noe Kyeong Kim
Phase II Study of Chemotherapy with ACNU Plus Cisplatin Followed by Cranial Irradiation in Patients with Newly Diagnosed Glioblastoma Multiforme
Journal of Neuro-Oncology, 60 (2): 171-176, November 2002 

Glas M, Hundsberger T, Stuplich M, Wiewrodt D, Kurzwelly D, Nguyen-Huu B, Rasch K, Herrlinger U
Nimustine (ACNU) Plus Teniposide (VM26) in Recurrent Glioblastoma
Oncology. 2009 Feb 13;76(3):184-189. [Epub ahead of print]
  Abstract

Mizumoto M, Tsuboi K, Igaki H, Yamamoto T, Takano S, Oshiro Y, Hayashi Y, Hashii H, Kanemoto A, Nakayama H, Sugahara S, Sakurai H, Matsumura A, Tokuuye K
Phase I/II Trial of Hyperfractionated Concomitant Boost Proton Radiotherapy for Supratentorial Glioblastoma Multiforme
Int J Radiat Oncol Biol Phys. 2009 Aug 19;. [Epub ahead of print]
  Abstract


Han JH, Park CK, Lee SH, Kim CY, Kim DW, Paek SH, Kim DG, Heo DS, Kim IH, Jung HW.
Preradiation Chemotherapy with ACNU-CDDP in Patients with Newly Diagnosed Glioblastoma: A Retrospective Analysis
Chemotherapy. 2009 Apr 22;55(3):145-154. [Epub ahead of print]
  Abstract

Happold C, Roth P, Wick W, Steinbach JP, Linnebank M, Weller M, Eisele G.
ACNU-based chemotherapy for recurrent glioma in the temozolomide era
J Neurooncol. 2008 Nov 6. [Epub ahead of print]
  Abstract

Kim IH, Park CK, Heo DS, Kim CY, Rhee CH, Nam DH, Lee SH, Han JH, Lee SH, Kim TM, Kim DW, Kim JE, Paek SH, Kim DG, Kim IA, Kim YJ, Kim JH, Park BJ, Jung HW.
Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial.
J Neurooncol. 2010 Nov 4. [Epub ahead of print]
  Abstract |   Reprint |   Related articles

Dirk Vordermark, Klemens Ruprecht, Peter Rieckmann, Wolfgang Roggendorf, Giles H Vince, Monika Warmuth-Metz, Oliver Kölbl, and Michael Flentje
Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)
BMC Cancer. 2006 Oct 18;6:247
Abstract | Full Text | Reprint


Recurrent Tumors


Saito R, Sonoda Y, Kumabe T, Nagamatsu K, Watanabe M, Tominaga T.
Regression of recurrent glioblastoma infiltrating the brainstem after convection-enhanced delivery of nimustine hydrochloride.
J Neurosurg Pediatr. 2011 May;7(5):522-6.
  Abstract |   Related articles


Gliomas


Kaneko S, Abe H, Aida T, Tokuda K, Tsuru M, Kitaoka K, Sato M, Iwakuma T, Ueno K, Kashiwaba T
Evaluation of radiation immunochemotherapy in the treatment of malignant glioma. Combined use of ACNU, VCR and PS-K
Hokkaido Igaku Zasshi 1983 Nov;58(6):622-30 

The Neuro-Oncology Working Group Of The German Cancer Society
Neuro-oncology working group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma
J Clin Oncol. 2003 Sep 1;21(17):3276-84 (PDF Full Text)

Wolff JE, Berrak S, Koontz Webb SE, Zhang M
Nitrosourea efficacy in high-grade glioma: a survival gain analysis summarizing 504 cohorts with 24193 patients
J Neurooncol. 2008 Feb 6; [Epub ahead of print]
Abstract


Medulloblastoma


Yoshimura J, Nishiyama K, Mori H, Takahashi H, Fujii Y
Intrathecal chemotherapy for refractory disseminated medulloblastoma
Childs Nerv Syst. 2007 Dec 5; [Epub ahead of print]
Full Text | Reprint

 

This website is certified by Health On the Net Foundation. Click to verify. HOME ARCHIVES OF NEURO-ONCOLOGY CURRENT NEURO-ONCOLOGY NEWS CLINICAL NEURO-ONCOLOGY LIBRARY
DATABASE: Classification | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Management | Prognosis | Psychosocial Aspects | Stem Cells | Treatment
SERVICES
: About BrainLife | Children's Corner | E-mail Alerts | Journals | Links |
Motto, Dedication, etc. | Patients & Caregivers | Privacy Policy | Search | SiteMap bottom
This site complies with the HONcode standard for trustworthy health information: verify here